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Background: Interstitial microdeletions in 1p are extremely rare, as very few cases have been reported postnatally
and only one prenatally, yet. There is a variability of phenotypic findings such as hypotonia, facial dysmorphisms,
mild microcephaly, with being most common developmental delay.
Case presentation: The present case involved a female fetus with an interstitial deletion on 1p, presenting with
micrognathia in the 2nd trimester routine ultrasound examination. Array-based comparative genomic hybridization
(a-CGH) revealed a 2,7 Mb deletion located on 1p34.3 which could not be detected by standard karyotyping.
Conclusions: This is the first prenatal case of an interstitial deletion in 1p34.3 with facial dysmorphism detected by
a-CGH. Due to the use of a-CGH techniques submicroscopic imbalances could be detected, and a refined
genotype-phenotype correlation could be achieved.
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Array-based comparative genomic hybridization (array
CGH) is a powerful method that allows the detection of
submicroscopic alterations in human genome and thus
identifies underlying genetic causes that may contribute
to various phenotypic abnormalities. On the short arm
of chromosome 1, a subtelomeric microdeletion on 1p36
has been well established [1], but interstitial microdele-
tions in chromosome 1p have rarely been reported. Like-
wise, some efforts have been made to correlate
submicroscopic deletions in 1p34 with a phenotype and
such deletions have been associated with dysmorphic
features and severe developmental delay [2, 3].
Furthermore, specific genes of this chromosomal re-
gion have been associated with distinct phenotypic
malformations. More precisely, GLUT1 deficiency may* Correspondence: manolakos@atg-labs.gr
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hyperactivity and developmental delay [3, 4], RIMS3 is
considered to be a novel candidate for autism [5],
GRIK3 has also been associated with developmental
delay [6], and AGO1/AGO3 may be responsible for
neurocognitive deficits [7]. Furthermore, the chromo-
somal region 1p34 has been characterized as a tumor
suppressor gene locus suggesting a role in cancer de-
velopment [8].
Until today, there is only 1 case reported in the litera-
ture with an interstitial deletion of 1p that was diag-
nosed prenatally. The deletion spanned the region
1p36.11 to 1p34.3 and was detected by banding cytogen-
etic method and fluorescence in situ hybridization
(FISH) [9]. Here, we report a 2.7 Mb de novo interstitial
deletion within chromosomal subband 1p34.3, which
was diagnosed prenatally in a fetus with micrognathia.Case presentation
At 22 weeks of gestation a 34-year-old pregnant fe-
male was referred to our lab for prenatal geneticle is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
changes were made. The Creative Commons Public Domain Dedication waiver
ro/1.0/) applies to the data made available in this article, unless otherwise stated.
Table 1 Autopsy observations of the embryo and the placenta
Embryo Placenta
• Cleft palate
• Craniofacial malformations (severe
posterior micrognathia, microtia)
• Narrow trunk with 11 pairs of
thoracic and 1 pair of nuchal sides
• Abnormal position of fingers
• Talipes varus
• Knee flexion
• Dilatation of fourth ventricle
• Malformation of mitral valve
• Underweight placenta with
increased fetus-placenta ratio
• Mitral decidual arteriopathy
• Low-grade acute chorioamniotis
maternally derived, without any
inflammatory reaction observed
in the fetus
Fig. 1 Array-CGH analysis illustrating in depth the de novo interstitial micro
chromosome 1 at chromosomal band 1p34.3 (location: 36,901,642 − 39,606
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micrognathia detected at the routine 2nd trimester
ultrasound examination. The prospective parents
were healthy and of Greek origin. This was their
first pregnancy and they had no previous medical
history. The molecular cytogenetic analysis (see
below) revealed a deletion in 1p. Genetic counseling
was offered to the couple. At the parents’ request
the pregnancy was terminated at 22 weeks of gesta-
tion. Subsequently, the female fetus was sent for an
autopsy.deletion of approximately 2,7 Mb in size on the short arm of
,756 using build GRCh37 (hg19))
Table 2 OMIM genes included in the deleted region
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The fetus was of normal growth according to the weeks
of gestation (~21/40) weighing 438 g without essential
autolytic changes of intrauterine death. The autopsy’s
observations are shown in Table 1.
The mitral decidual arteriopathy observed in the pla-
centa indicated pathological implantation, which pos-
sibly caused uteroplacental insufficiency and relevant
gestational complications uteroplacental ischemia. In the
present case, however it is possible that the decidual
arteriopathy and the underweight placenta just reflect
the pathological implantation and the abnormal placen-

















MACF1 608271Molecular cytogenetic analysis
Molecular karyotype analysis by array CGH using “Illu-
mina Cytochip Focus Constitutional array with BAC
technology” was performed on DNA isolated from un-
cultured amniocytes according to the manufacturer’s
protocol. The Illumina Cytochip Focus Constitutional
array is a commercially available whole-genome BAC
array with a median resolution of 0.5−1 Mb. (Cytochip
Focus Constitutional, Illumina).
The parent’s blood derived DNA samples were prepared
from peripheral blood leukocytes (Promega, Madison, WI,
USA). Array data was analyzed using Bluefuse software
analysis (BlueGnome Ltd., UK) using GRCh37/hg19
UCSC assembly and compared to known duplication
listed in public available databases [Database of Genomic
Variants (DGV, http://projects.tcag.ca/variation/webcite),
ENSEMBL (http://www.ensembl.orgwebcite), and DE-
CIPHER (http://decipher.sanger.ac.ukwebcite) Accessed at
25/01/2015].
A female profile was revealed with a 2,7 Mb deletion
at chromosome 1p34.3 extending from position
36,901,642 to 39,606,756 (GRCh37/hg19 Feb.2009)
(Fig. 1). No other copy number variant was detected at
the referred sample. Using the UCSC Genome Browser
and the OMIM database we observed that the deleted
region contains 27 OMIM genes, listed in Table 2. Par-
ental blood testing with a-CGH method revealed that
the deletion occured de novo.Discussion
We report a prenatal case, which involves an interstitial
microdeletion within chromosome 1p34.3. Most of the
cases that have been reported with similar deletions are
postnatal and only 1 is a prenatal report [9]. There is no
specific phenotype or known syndrome that has been as-
sociated to this kind of deletion. To our knowledge there
are only about 8 comparable patients, and in most cases
the detected rearrangement was de novo as in our case.
These patients showed a variability of phenotypicfindings with developmental delay to be apparently
present in almost all of them (Table 3).
Takenounci et al. [6] reported about a young girl,
showing severe developmental delay, mild retrognathia
and slightly downslanting papebral fissures. The deleted
chromosomal regions in this proband and in the present
case encompass the GRIK3 gene which was suggested to
be responsible for neurodevelopmental manifestations
by Takenounci et al. [6].
Another gene that might contribute to craniofacial
malformation and it is haploinsufficient in this case is
SNIP1. Puffenberger et al. [10] identified a homozy-
gous 1097A-G transition in the SNIP1 gene in 3
Amish patients with severe craniofacial dysmorphism.
Western blot analysis showed decreased levels of the
mutant homologous murine protein, suggesting that it
is unstable. Puffenberger et al. [10] postulated that
decreased abundance of SNIP1 likely affects c-Myc
activity, TGF-beta, and NF-kappa-B signaling, as
Table 3 Overview of patients with 1p34.3 deletion. NM: Not Mentioned
Tokita et al. [7]
proband 1
Tokita et al. [7]
proband 2
Tokita et al. [7]
proband 3
Tokita et al. [7]
proband 4








Gender F F F M M M F F
Delivery age
(weeks)
38 37 42 41 38 NM NM 37
Pregnancy and
delivery







No Yes Yes Yes Yes No No Yes
Age 3y 9 m 10y 6 m 18y 17 m 13y 13y 8y 8y
Height
(percentile)
24th 25th 50th <1st 90th-97th 50th 50th NM
Weight
(percentile)
15th 2nd 5th 1st >97th 50th 50th NM
OFC
(percentile)
3rd-10th 25th <<3rd <1st 2nd-10th 50th 50th NM
Developmental
delay
Yes Yes Yes Yes Yes No No Yes
Facial
deformities
Yes Yes Yes Yes Yes Yes No No
Hypotonia Yes Yes Yes Yes Yes No No No
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and this effect may cause abnormal brain and skull
development.
Recent data from Tokita et al. [7] describe five chil-
dren with microdeletions on 1p34.3 that showed,
apart from hypotonia and developmental delay, cra-
niofacial dysmorphisms such as retrognathia and
small ears, as well feet and fingers malformations.
The deletion that we report here overlaps with 4 de-
leted chromosomal loci, except a region between
38,622,840–39,141,084 (Fig. 2). In this region there is
the 5’ end of MACF1 gene (chr1:39,084,166–
39,487,137). MACF1 protein was found to be greatly
up-regulated upon differentiation of myoblasts into
myotubes [14], while Kodama et al. [15] showed that
mouse MACF1 (or Acf7) is an essential integrator of
microtubule-actin dynamics. In the absence of MACF1
the consequences were long, less stable microtubulesFig. 2 Schematic presentation of 1p34.3 deletionswith skewed cytoplasmic trajectories and altered dy-
namic instability [15]. Taking these into account it
might be explained the fact that the present case ex-
hibited dilatation of fourth ventricle and malformation
of mitral valve, while none of the cases of Table 3
presented any heart defect.
The fetal autopsy also showed pathological implant-
ation of the fetus, and a possible explanation is that
the placenta exhibited abnormal extracellular matrix.
Ephrins are membrane-bound proteins that interact
with Eph receptors, and have a crucial role in many
developmental processes like guidance of neuron axon
growth cones, cell migration and formation of tissue
boundaries [16]. In the present case, 1 Eph receptor,
EPHA10, is haploinsufficient, and is possibly 1 of the
causes of improper implantation of the fetus, due to
abnormal interaction of placental and uterus tissue
boundaries.
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Array-based comparative genomic hybridization has
been placed in the routine prenatal genetic testing and
novel microscopic imbalances through the genome come
to light. The comparison with similar findings in other
patients is still not possible in most of the cases, but col-
lecting data from such cases is crucial for genetic coun-
selors to interpret prenatal cases, and achieve more
accurate reports about clinical manifestations.
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